Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Inspire Medical Systems Inc (NYSE: INSP) was $78.54 for the day, up 2.24% from the previous closing price of $76.82. In other words, the price has increased by $2.24 from its previous closing price. On the day, 1.07 million shares were traded. INSP stock price reached its highest trading level at $80.59 during the session, while it also had its lowest trading level at $76.4.
Ratios:
Our analysis of INSP’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.32. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 6.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On September 02, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $150.
Truist Downgraded its Buy to Hold on August 05, 2025, while the target price for the stock was maintained at $125.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 29 ’25 when Buchholz Richard sold 11,000 shares for $93.39 per share. The transaction valued at 1,027,290 led to the insider holds 44,867 shares of the business.
Buchholz Richard bought 11,000 shares of INSP for $1,027,349 on Aug 29 ’25. On May 19 ’25, another insider, Rondoni John, who serves as the insider of the company, sold 1,734 shares for $149.38 each. As a result, the insider received 259,025 and left with 13,766 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2322766848 and an Enterprise Value of 2054930816. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.50, and their Forward P/E ratio for the next fiscal year is 51.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.70 while its Price-to-Book (P/B) ratio in mrq is 3.43. Its current Enterprise Value per Revenue stands at 2.386 whereas that against EBITDA is 39.376.
Stock Price History:
The Beta on a monthly basis for INSP is 1.15, which has changed by -0.6176986 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $216.01, while it has fallen to a 52-week low of $70.77. The 50-Day Moving Average of the stock is -9.43%, while the 200-Day Moving Average is calculated to be -44.44%.
Shares Statistics:
INSP traded an average of 1.13M shares per day over the past three months and 1012520 shares per day over the past ten days. A total of 29.57M shares are outstanding, with a floating share count of 26.73M. Insiders hold about 9.62% of the company’s shares, while institutions hold 112.28% stake in the company. Shares short for INSP as of 1757894400 were 2617345 with a Short Ratio of 2.31, compared to 1755216000 on 2291236. Therefore, it implies a Short% of Shares Outstanding of 2617345 and a Short% of Float of 11.88.
Earnings Estimates
The dynamic stock of Inspire Medical Systems Inc (INSP) is currently attracting attention from 10.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.67, with high estimates of $0.73 and low estimates of $0.55.
Analysts are recommending an EPS of between $1.07 and $0.5 for the fiscal current year, implying an average EPS of $0.99. EPS for the following year is $1.6, with 12.0 analysts recommending between $2.52 and $0.94.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 17 analysts. It ranges from a high estimate of $222.7M to a low estimate of $210.41M. As of. The current estimate, Inspire Medical Systems Inc’s year-ago sales were $203.19MFor the next quarter, 17 analysts are estimating revenue of $264.74M. There is a high estimate of $271.2M for the next quarter, whereas the lowest estimate is $261.4M.
A total of 18 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $905.64M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $903.65M. In the same quarter a year ago, actual revenue was $802.8MBased on 18 analysts’ estimates, the company’s revenue will be $1.03B in the next fiscal year. The high estimate is $1.06B and the low estimate is $998.99M.
